Antibody-modified liposomes for cancer chemotherapy.
Liposomes, phospholipids, nanosized bubbles with a bilayered membrane structure, have drawn a lot of interest as pharmaceutical carriers for drugs and genes. In particular, liposomes are widely used for drug delivery into tumors. In many cases, to enhance the efficacy of the liposomal drugs, drug-loaded liposomes are targeted to the tumors by means of different specific ligands, such as monoclonal antibodies. Thus, this review analyzes the application of antibody-targeted liposomes loaded with various chemotherapeutic agents and various liposomal products under development at experimental and preclinical level. The papers published on the subject of cancer-targeted liposomes mainly over the last 10 - 15 years are discussed. Antibody-targeted liposomes loaded with anticancer drugs demonstrate high potential for clinical applications.